HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Thierry Lecomte Selected Research
Thierry Lecomte Research Topics
Disease
55
Colorectal Neoplasms (Colorectal Cancer)
12/2022 - 08/2002
35
Neoplasms (Cancer)
12/2022 - 08/2002
14
Adenocarcinoma
01/2022 - 12/2014
11
Neoplasm Metastasis (Metastasis)
12/2022 - 01/2005
8
Pancreatic Neoplasms (Pancreatic Cancer)
05/2020 - 06/2002
6
Rectal Neoplasms (Rectal Cancer)
04/2022 - 08/2019
5
Microsatellite Instability
05/2022 - 07/2016
5
Crohn Disease (Crohn's Disease)
01/2022 - 11/2003
5
Colonic Neoplasms (Colon Cancer)
01/2022 - 12/2009
5
Stomach Neoplasms (Stomach Cancer)
01/2022 - 04/2016
5
Neutropenia
03/2021 - 01/2010
3
Disease Progression
01/2022 - 10/2011
3
Hepatocellular Carcinoma (Hepatoma)
03/2021 - 12/2008
2
Biliary Tract Neoplasms (Biliary Tract Cancer)
01/2022 - 09/2015
2
Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2022 - 02/2021
2
Ankylosing Spondylitis
01/2022 - 10/2016
2
Rheumatoid Arthritis
01/2022 - 10/2016
2
Thrombocytopenia (Thrombopenia)
03/2021 - 01/2017
2
COVID-19
01/2021 - 01/2020
2
Neuroendocrine Carcinoma
06/2020 - 10/2015
2
Mucositis
12/2019 - 01/2017
2
Fatigue
12/2019 - 01/2017
2
Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer)
10/2019 - 02/2015
2
Gastrointestinal Neoplasms (Gastrointestinal Cancer)
05/2006 - 04/2005
1
Frailty
01/2022
1
Cachexia
01/2022
1
Necrosis
01/2022
1
Primitive Neuroectodermal Tumors (PNET)
01/2022
1
Sarcopenia
11/2021
1
Esophageal Stenosis (Esophageal Stricture)
09/2021
1
Asthenia
03/2021
1
Hemorrhage
03/2021
1
Liver Failure
03/2021
1
Lymphopenia (Lymphocytopenia)
01/2021
Drug/Important Bio-Agent (IBA)
12
Monoclonal Antibodies
IBA
01/2022 - 10/2009
12
Fluorouracil (Carac)
FDA Link
Generic
12/2020 - 06/2002
10
Gemcitabine
FDA Link
09/2019 - 06/2002
9
Bevacizumab (Avastin)
FDA Link
12/2022 - 12/2008
9
Cetuximab (Erbitux)
FDA Link
01/2022 - 09/2008
7
Leucovorin (Folinic Acid)
FDA Link
12/2020 - 06/2002
7
Irinotecan (Camptosar)
FDA Link
Generic
12/2020 - 01/2010
6
Biomarkers (Surrogate Marker)
IBA
01/2021 - 03/2015
5
folfirinox
IBA
01/2022 - 09/2015
5
Proteins (Proteins, Gene)
FDA Link
01/2022 - 08/2013
5
ErbB Receptors (EGF Receptor)
IBA
01/2021 - 10/2009
4
Calcium
IBA
05/2022 - 06/2016
4
Pharmaceutical Preparations
IBA
01/2022 - 12/2008
4
130-nm albumin-bound paclitaxel
IBA
09/2019 - 09/2015
4
Oxaliplatin (Eloxatin)
FDA Link
Generic
12/2018 - 05/2006
3
aflibercept
IBA
12/2022 - 01/2020
3
Immune Checkpoint Inhibitors
IBA
04/2022 - 01/2021
3
Sunitinib (Sutent)
FDA Link
01/2022 - 12/2008
3
Infliximab (Remicade)
FDA Link
01/2022 - 12/2015
3
Ramucirumab
IBA
01/2022 - 01/2018
3
Circulating Tumor DNA
IBA
12/2021 - 07/2019
3
Platinum
IBA
06/2020 - 09/2015
3
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2018 - 11/2016
3
Biological Products
IBA
11/2016 - 01/2009
2
Calcibiotic Root Canal Sealer
IBA
04/2022 - 08/2017
2
Calcium-Activated Potassium Channels (Calcium-Activated Potassium Channel)
IBA
01/2022 - 04/2019
2
Calcium Channels (Calcium Channel)
IBA
01/2022 - 04/2019
2
Doxorubicin (Adriamycin)
FDA Link
Generic
01/2022 - 03/2021
2
Aerosols
IBA
01/2022 - 09/2021
2
Somatostatin (Somatotropin Release-Inhibiting Factor)
IBA
01/2022 - 02/2021
2
Everolimus
FDA Link
01/2022 - 12/2019
2
Cisplatin (Platino)
FDA Link
Generic
01/2022 - 06/2002
2
Bilirubin
IBA
03/2021 - 12/2014
2
Panitumumab (Vectibix)
FDA Link
01/2021 - 02/2018
2
Angiopoietin-2
IBA
10/2020 - 03/2015
2
eryaspase
IBA
05/2020 - 01/2020
2
Enzymes
IBA
12/2019 - 06/2004
2
Indigo Carmine (Indigo Blue)
IBA
10/2019 - 02/2015
2
Carcinoembryonic Antigen
IBA
01/2018 - 11/2016
2
Matrix Metalloproteinases (MMPs)
IBA
04/2005 - 01/2005
1
Curcumin
IBA
05/2022
1
Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)
IBA
01/2022
1
Peptides (Polypeptides)
IBA
01/2022
1
Potassium
IBA
01/2022
1
Paclitaxel (Taxol)
FDA Link
Generic
01/2022
1
encorafenib
IBA
01/2022
1
Ubiquitin
IBA
01/2022
1
Proteasome Endopeptidase Complex (Proteasome)
IBA
01/2022
1
pembrolizumab
IBA
10/2021
1
Hydrogels
IBA
09/2021
1
Ga(III)-DOTATOC
IBA
02/2021
1
durvalumab
IBA
01/2021
1
Catenins
IBA
01/2021
1
taxane
IBA
01/2021
1
Crizotinib
IBA
01/2021
1
MicroRNAs (MicroRNA)
IBA
01/2021
1
COVID-19 Vaccines
IBA
01/2021
Therapy/Procedure
34
Drug Therapy (Chemotherapy)
04/2022 - 09/2004
20
Therapeutics
01/2022 - 06/2002
4
Neoadjuvant Therapy
04/2022 - 06/2020
3
Chemoradiotherapy
01/2021 - 10/2015
2
Microbubbles
01/2022 - 01/2019
2
Adjuvant Chemotherapy
01/2017 - 07/2016
1
Immunotherapy
04/2022
1
Enhanced Recovery After Surgery
01/2022
1
Aftercare (After-Treatment)
01/2022